DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is presenting the results of a new study at the 14th International Conference on Advanced Technologies and Treatments for Diabetes (“ATTD”). Titled “Impact of Digital Intervention Engine on Diabetes Self-Management,” the study analyzes personalized digital interventions and the impact they have on clinical … Continue reading InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Present Study Results Showing Impact of Personalized Digital Interventions at Upcoming Conference